Skip to main content
    M

    Myomo Inc (MYO)

    Official site

    HEALTHCARE • MEDICAL DEVICES • AMEX

    $1.03
    -0.20 (-16.26%)

    Market Cap: $49.32M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    70%(26/37)
    Avg Surprise
    +13.16%
    Streak
    3 Q

    Upcoming Estimates

    Reports Mar 8, 2027 after closePeriod ending Dec 31, 2026
    EPS Consensus-$0.07
    Range-$0.08 - -$0.06
    6 analysts
    Revenue Consensus
    $12.32M
    Range$11.37M - $13.10M
    6 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.08
    Range-$0.10 - -$0.06
    3 analysts
    EPS Revisions
    2
    0
    30d
    EPS Estimate DriftChange to current
    90d ago-$0.08-2.3%
    60d ago-$0.07-9.6%
    30d ago-$0.07-9.6%
    7d ago-$0.07-9.6%
    Current-$0.08
    Revenue Consensus
    $10.94M
    Range$9.50M - $11.71M
    4 analysts

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-5.91xFCF Yield-16.92%
    Profitability
    Profit Margin-33.50%Operating Margin-19.30%
    ROE-123.80%ROIC-51.95%
    Financial Health
    Debt/Equity7.48xInterest CoverageN/A
    Current Ratio1.92xQuick Ratio1.66x
    Trading Statistics
    Beta1.71Avg Volume251.19K
    52-Week High$1.8952-Week Low$0.60

    Technical Indicators Dashboard

    As of Nov 16, 2026, the price is 24.1% below its 50-day moving average, and the 50-day average is above the 200-day average. The 14-day RSI is 36.2, in the neutral range between 30 and 70.

    Moving Averages

    SMA 10$1.24
    SMA 20$1.23
    SMA 50$1.36
    SMA 200$1.10
    EMA 10$1.21
    EMA 20$1.25
    EMA 50$1.31
    EMA 200$1.27

    MACD

    Line: -0.05Signal: -0.04Hist: -0.01

    ADX

    ADX: 17.3+DI: 19.5-DI: 23.2

    Aroon & PSAR

    Aroon Up84.0
    Aroon Down100.0
    PSAR$1.46

    Bollinger Bands

    Upper Band$1.38
    Lower Band$1.09
    %B Position2278%(Upper)
    Band Width-0.23

    RSI (14-Day)

    Neutral
    36.2

    Momentum Oscillators

    Stoch %K12.9
    Stoch %D20.8
    Williams %R-100.0
    ROC (10d)-14.2%
    Momentum-0.17
    CCI (20d)-272.8
    MFI (14d)39.8

    Volatility Measures

    ATR (14d)$0.12(11.4%)
    StdDev (20d)0.07
    Hist Vol105.7%(High)

    Volume Flow

    VWAP$1.09
    OBV-25.7M
    AD Line-36.9M
    CMF (20d)-0.294

    Volume Metrics

    Avg Vol (20d)250.7K
    Vol Ratio2.5x(High)
    VWMA (20d)$1.22

    Pivot Points

    R3$1.34
    R2$1.30
    R1$1.27
    Pivot Point$1.23
    S1$1.20
    S2$1.16
    S3$1.13

    Advanced Oscillators

    TSI-12.09
    Ultimate Osc35.0
    KST-100.52

    Financial Performance

    Related GNG Research

    No research available

    Be the first to write about MYO

    Gov Obligations (TTM)
    $789,465
    Gov Obligations / Revenue
    1.9%
    Obligations YoY
    N/A
    Active Awards
    32
    New Awards (TTM)
    29
    Avg Remaining Term
    3.7 mo

    Top agency: Department of Veterans Affairs at 100.0% of trailing twelve month obligations across 1 agencies

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    MYO Valuation

    GNG's valuation label for MYO is Undervalued.

    P/FCF
    -5.9x
    P/B
    16.3x
    All MYO metrics

    MYO Profitability: Margins, ROIC and FCF

    Myomo (MYO) has a gross margin of 70.1%, an operating margin of -19.3% and a net margin of -33.5%. It posts -51.9% ROIC and a -16.7% FCF margin.

    Gross margin
    70.1%
    Operating margin
    -19.3%
    Net margin
    -33.5%
    ROIC
    -51.9%
    ROE
    -123.8%
    FCF margin
    -16.7%
    FCF yield
    -16.9%
    MYO financial statements

    The companies most similar to Myomo (MYO) include Microbot Medical, Envoy Medical and Electrocore LLC.

    Sector: Healthcare

    Companies most similar to Myomo

    MYO Analyst Ratings

    Myomo (MYO) has a Buy consensus from 5 analysts: 5 Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell.

    Consensus
    Buy
    Analysts
    5
    Strong Buy
    1
    Buy
    4
    Hold
    0
    Sell
    0
    Strong Sell
    0
    MYO stock forecast

    MYO Bull Case vs Bear Case

    Bull case

    • MYO grew quarterly revenue 21.3% year over year.
    • 100.0% of MYO's analyst ratings are Buy or Strong Buy.

    Bear case

    • MYO has a -33.5% net profit margin.
    • MYO has a debt-to-equity ratio of 7.5x.

    MYO Earnings: Beat Rate and Next Report

    Myomo (MYO) beat the EPS estimate in 5 of the last 8 quarters (62.5%). Its next report is confirmed on Mar 8, 2027.

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    16.8%
    EPS estimate (fiscal period ending Dec 31, 2026)
    -$0.07
    MYO earnings history

    MYO Earnings Date

    MYO reports Mar 8, 2027, after the close. The date is confirmed.

    MYO Earnings Call

    The latest MYO earnings call transcript on file is labeled 2026Q1.

    Read the 2026Q1 transcript

    See insider activity

    Updated Nov 9, 2026. Built from end-of-day prices, company filings and consensus analyst estimates. Methodology

    Frequently Asked Questions About MYO

    When does MYO report earnings?

    Myomo Inc (MYO) is confirmed to report earnings on Mar 8, 2027.

    Does MYO pay dividends?

    Myomo Inc (MYO) does not currently pay a regular dividend.

    What is MYO's market cap?

    Myomo Inc (MYO) has a market capitalization of $49.32M with a current stock price of $1.03.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.